Effets de paramètres d'opération sur la décantation de boues biologiques d'une unité de traitement d'eaux usées de raffinerie

La qualité de l'effluent des systèmes de biotraitement par boues activées est souvent limitée par la performance de l'unité de décantation. Cette étude analyse les causes possibles des difficultés d'opération rencontrées dans la décantation des boues évacuées aux décanteurs secondaires d'une raffinerie de pétrole. Les objectifs visent à déterminer et à quantifier l'effet des paramètres d'opération qui affectent le fonctionnement du décanteur, en les reliant si possible à son mauvais fonctionnement, à évaluer de l'ajout d'alun et à proposer des méthodes correctives pour améliorer l'efficacité de décantation.L'étude montre que :- l'efficacité des décanteurs sera améliorée si le niveau d'oxygène dissous et la concentration en matières totales en suspension (MTS) dans le bassin d'aération sont respectivement maintenus entre 0,9 à 1,3 ppm et 4 300 à 4 800 mg/L;- le pH de la liqueur mixte ne semble pas influencer la décantabitité;- l'addition d'alun doit être évitée ou maintenue inférieure à 50 mg/L;- l'agitation et les vitesses linéaires élevées dans les conduites d'alimentation des décanteurs doivent être évitées.The wastewater treatment systems built in the seventies for treating the effluents from oil refineries often fail to comply with new environmental standards. The present study focuses mainly on the problem of sludge settling in the clarifiers. The purpose of this work was to determine the effect of various parameters on the settling characteristics of the activated sludge, to evaluate the rote of alun as a flocculating agent and to characterize the operation of the clarifiers primarily as it relates to the settling problem. The influence of the quantity of the alun added and of the stirring speed on the settling characteristics of the sludge were determined in jar tests. The effects, on the performance of the clarifiers, of the level of dissolved oxygen in the bioreactor, of the pH and of the concentration in total suspended solids (TSS) maintained in the mixed liquor, were also investigated.The studies on the sludge settleability led to the following conclusions :- the concentration in dissolved oxygen and the concentration in TSS in the aeration tank are two parameters which have a critical effect on the effluent quality. The optimal operating intervals for these parameters are from 0.9 to 1.3 ppm for dissolved oxygen and from 4 300 to 4 800 mg/L for the TSS;- the pH of the mixed liquor is not a main factor and does not seem to have any effect on the sludge settleability;- the addition of alum in excess of 50 mg/L has an adverse effect on the sludge settling characteristics. Addition of alum below this level, however, improves the clarity of the residual liquor. Nevertheless, the addition of this flocculating agent is not recommended;- the high flowrates and violent mixing in the piping system used to feed the mixed liquor from the aeration tank to the clarifiers adversely affects the solid-liquid separation in the clarifiers.By simply stopping the addition of the flocculating agent, maintaining the dissolved oxygen concentration between 1 to 2 ppm and the TSS between 4 300 to 4 800 mg/L in the wastewater treatment unit, it was possible to improve substantially the quality of the effluent and thus meet the environmental standards

An improved continuous compositional-spread technique based on pulsed-laser deposition and applicable to large substrate areas

A new method for continuous compositional-spread (CCS) thin-film fabrication based on pulsed-laser deposition (PLD) is introduced. This approach is based on a translation of the substrate heater and the synchronized firing of the excimer laser, with the deposition occurring through a slit-shaped aperture. Alloying is achieved during film growth (possible at elevated temperature) by the repeated sequential deposition of sub-monolayer amounts. Our approach overcomes serious shortcomings in previous in-situ implementations of CCS based on sputtering or PLD, in particular the variations of thickness across the compositional spread and the differing deposition energetics as function of position. While moving-shutter techniques are appropriate for PLD-approaches yielding complete spreads on small substrates (i.e. small as compared to distances over which the deposition parameters in PLD vary, typically about 1 cm), our method can be used to fabricate samples that are large enough for individual compositions to be analyzed by conventional techniques, including temperature-dependent measurements of resistivity and dielectric and magnetic and properties (i.e. SQUID magnetometry). Initial results are shown for spreads of (Sr,Ca)RuO$_3$.Comment: 6 pages, 8 figures, accepted for publication in Rev. Sci. Instru

The impact of phenotypic and genetic heterogeneity on results of genome wide association studies of complex diseases

Phenotypic misclassification (between cases) has been shown to reduce the power to detect association in genetic studies. However, it is conceivable that complex traits are heterogeneous with respect to individual genetic susceptibility and disease pathophysiology, and that the effect of heterogeneity has a larger magnitude than the effect of phenotyping errors. Although an intuitively clear concept, the effect of heterogeneity on genetic studies of common diseases has received little attention. Here we investigate the impact of phenotypic and genetic heterogeneity on the statistical power of genome wide association studies (GWAS). We first performed a study of simulated genotypic and phenotypic data. Next, we analyzed the Wellcome Trust Case-Control Consortium (WTCCC) data for diabetes mellitus (DM) type 1 (T1D) and type 2 (T2D), using varying proportions of each type of diabetes in order to examine the impact of heterogeneity on the strength and statistical significance of association previously found in the WTCCC data. In both simulated and real data, heterogeneity (presence of "non-cases") reduced the statistical power to detect genetic association and greatly decreased the estimates of risk attributed to genetic variation. This finding was also supported by the analysis of loci validated in subsequent large-scale meta-analyses. For example, heterogeneity of 50% increases the required sample size by approximately three times. These results suggest that accurate phenotype delineation may be more important for detecting true genetic associations than increase in sample size

Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)

Aim<p></p> To describe the baseline characteristics and treatment of the patients randomized in the PARADIGM-HF (Prospective comparison of ARNi with ACEi to Determine Impact on Global Mortality and morbidity in Heart Failure) trial, testing the hypothesis that the strategy of simultaneously blocking the renin–angiotensin–aldosterone system and augmenting natriuretic peptides with LCZ696 200 mg b.i.d. is superior to enalapril 10 mg b.i.d. in reducing mortality and morbidity in patients with heart failure and reduced ejection fraction.<p></p> Methods<p></p> Key demographic, clinical and laboratory findings, along with baseline treatment, are reported and compared with those of patients in the treatment arm of the Studies Of Left Ventricular Dysfunction (SOLVD-T) and more contemporary drug and device trials in heart failure and reduced ejection fraction.<p></p> Results<p></p> The mean age of the 8442 patients in PARADIGM-HF is 64 (SD 11) years and 78% are male, which is similar to SOLVD-T and more recent trials. Despite extensive background therapy with beta-blockers (93% patients) and mineralocorticoid receptor antagonists (60%), patients in PARADIGM-HF have persisting symptoms and signs, reduced health related quality of life, a low LVEF (mean 29 ± SD 6%) and elevated N-terminal-proB type-natriuretic peptide levels (median 1608 inter-quartile range 886–3221 pg/mL).<p></p> Conclusion<p></p> PARADIGM-HF will determine whether LCZ696 is more beneficial than enalapril when added to other disease-modifying therapies and if further augmentation of endogenous natriuretic peptides will reduce morbidity and mortality in heart failure and reduced ejection fractio